Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125620601 | 12562060 | 1 | I | 20160624 | 20160715 | 20160715 | PER | US-ELI_LILLY_AND_COMPANY-US201606009142 | ELI LILLY AND CO | 78.00 | YR | M | Y | 0.00000 | 20160715 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125620601 | 12562060 | 1 | PS | CIALIS | TADALAFIL | 1 | Oral | 20 MG, PRN | U | U | C497101A | 21368 | 20 | MG | TABLET | ||||
| 125620601 | 12562060 | 2 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125620601 | 12562060 | 1 | Erectile dysfunction |
| 125620601 | 12562060 | 2 | Benign prostatic hyperplasia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125620601 | 12562060 | Drug ineffective | |
| 125620601 | 12562060 | Headache | |
| 125620601 | 12562060 | Nasal congestion | |
| 125620601 | 12562060 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |